| Patent | Date |
|---|
Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy
Grant 10,793,628 - Lee , et al. October 6, 2 | 2020-10-06 |
RAD51 inhibitors and uses thereof
Grant 10,730,864 - Zhu , et al. | 2020-08-04 |
Novel RAD51 Inhibitors and Uses Thereof
App 20200048239 - ZHU; Jiewen ; et al. | 2020-02-13 |
RAD51 inhibitors and uses thereof
Grant 10,421,753 - Zhu , et al. Sept | 2019-09-24 |
Antagonists For Interleukin-17 Receptor B (il-17rb) And Its Ligand Il-17b For Cancer Therapy
App 20180201672 - Lee; Wen-Hwa ; et al. | 2018-07-19 |
Novel RAD51 Inhibitors and Uses Thereof
App 20180057483 - ZHU; Jiewen ; et al. | 2018-03-01 |
Small molecule modifiers of the Hec1-Nek2 interaction in G2/M
Grant 9,670,197 - Lee , et al. June 6, 2 | 2017-06-06 |
Small Molecule Modifiers Of The Hec1-nek2 Interaction In G2/m
App 20160318918 - Lee; Wen-Hwa ; et al. | 2016-11-03 |
Small molecule modifiers of the HEC1-NEK2 interaction in G2/M
Grant 9,422,275 - Lee , et al. August 23, 2 | 2016-08-23 |
Massage Tool
App 20150272774 - LEE; Wen-Hwa | 2015-10-01 |
Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof
Grant 9,012,455 - Lee , et al. April 21, 2 | 2015-04-21 |
Small Molecule Modifiers Of The Hec1-nek2 Interaction In G2/m
App 20150105391 - Lee; Wen-Hwa ; et al. | 2015-04-16 |
Use Of Il-17e For Cancer Treatment
App 20130052157 - Furuta; Saori ; et al. | 2013-02-28 |
Compositions and methods for disruption of BRCA2-Rad51 interaction
Grant 8,293,764 - Lee , et al. October 23, 2 | 2012-10-23 |
Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
Grant 8,252,520 - Lee , et al. August 28, 2 | 2012-08-28 |
Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
App 20090312324 - Lee; Wen-Hwa ; et al. | 2009-12-17 |
Compositions and Methods for Disruption of BRCA2-Rad51 Interaction
App 20090221634 - Lee; Wen-Hwa ; et al. | 2009-09-03 |
Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
Grant 7,105,156 - Lee , et al. September 12, 2 | 2006-09-12 |
Method and compounds for inhibiting hec1 ativity for the treatment of proliferative diseases
App 20060140956 - Lee; Wen-Hwa ; et al. | 2006-06-29 |
Products and methods for controlling the suppression of the neoplastic phenotype
Grant 7,060,688 - Lee , et al. June 13, 2 | 2006-06-13 |
Products and methods for controlling the suppression of the neoplastic phenotype
App 20030181403 - Lee, Wen-Hwa ; et al. | 2003-09-25 |
Therapeutic use of the retinoblastoma susceptibility gene product
Grant 5,851,991 - Lee , et al. December 22, 1 | 1998-12-22 |
Nuclear mitotic phosphoprotein
Grant 5,710,022 - Zhu , et al. January 20, 1 | 1998-01-20 |
Genetic mechanisms of tumor suppression
Grant 5,532,220 - Lee , et al. July 2, 1 | 1996-07-02 |
ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product
Grant 4,942,123 - Lee , et al. July 17, 1 | 1990-07-17 |
| 